re: exceeding revenue forecasts
a wider market turnaround to biotechs/device makers should see PBI gain more acceptance. I believe the pulmo products have the potential to be blockbusters as they tap into indentified clinical needs. My understanding is the pulmo products are still on track, would love to see a US giant take our tech on ... Appears it will take some time for PBI to awaken from the slumber ... but when it does it will be hard to get large lines of stock. I think after the sell down on small volume we now have the problem of nervous placement holders stacking some bids in the .31, .31 range in a bid to get their cash back and hold onto the attaching options (or vice versa) ... this could slow things down for a month or two until big news or the sellers are shaken out.
PBI
premier bionics limited
